scholarly journals Cost and Efficacy of Therapies for Advanced Parkinson's Disease

10.5772/17862 ◽  
2011 ◽  
Author(s):  
Francesc Valldeoriola
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Advanced Parkinson’S Disease

Combining dopamine agonists of different dopamine receptor profiles in advanced Parkinson's disease

2004 ◽  
Vol 31 (S 1) ◽  
Author(s):  
F Sixel-Döring ◽  
M Rausch-Hertel ◽  
H Klinke ◽  
C Trenkwalder
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Dopamine Receptor ◽  
Dopamine Agonists ◽  
Advanced Parkinson’S Disease

scholarly journals Translating Evidence to Advanced Parkinson's Disease Patients: A Systematic Review and Meta‐Analysis

2021 ◽  
Author(s):  
Frouke A.P. Nijhuis ◽  
Rianne Esselink ◽  
Rob M.A. Bie ◽  
Hans Groenewoud ◽  
Bastiaan R. Bloem ◽  
...  
Keyword(s):  
Systematic Review ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Meta Analysis ◽  
Advanced Parkinson’S Disease

Bilateral Effects of Unilateral Subthalamic Nucleus Deep Brain Stimulation in Advanced Parkinson’s Disease

2006 ◽  
Vol 56 (2) ◽  
pp. 127-132 ◽  
Author(s):  
Sun J. Chung ◽  
Sang R. Jeon ◽  
Sung R. Kim ◽  
Young H. Sung ◽  
Myoung C. Lee
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Deep Brain Stimulation ◽  
Subthalamic Nucleus ◽  
Brain Stimulation ◽  
Advanced Parkinson’S Disease ◽  
Bilateral Effects ◽  
Deep Brain

scholarly journals Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson's Disease: A Systematic Review

2021 ◽  
Author(s):  
Taiji Tsunemi ◽  
Genko Oyama ◽  
Shinji Saiki ◽  
Taku Hatano ◽  
Jiro Fukae ◽  
...  
Keyword(s):  
Systematic Review ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Advanced Parkinson’S Disease

scholarly journals Unexplained worsening of parkinsonian symptoms in a patient with advanced Parkinson’s disease as the sole initial presentation of COVID-19 infection: a case report

2021 ◽  
Vol 57 (1) ◽  
Author(s):  
Walaa A. Kamel ◽  
Ismail Ibrahim Ismail ◽  
Mohamed Ibrahim ◽  
Jasem Y. Al-Hashel
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Viral Infections ◽  
Neurological Complications ◽  
Initial Presentation ◽  
Nasopharyngeal Swab ◽  
Initial Manifestation ◽  
Advanced Parkinson’S Disease ◽  
Case Presentation ◽  
Dystonic Posturing

Abstract Background Parkinson’s disease (PD) is a neurodegenerative condition that has been reported following viral infections in rare occasions. Several neurological complications have emerged in association with coronavirus disease 2019 (COVID-19), since its declaration as a pandemic. Herein, we present a novel case of unexplained worsening of PD as the sole initial presentation of COVID-19, in the absence of fever or respiratory symptoms. Case presentation A 56-year-old male with advanced PD presented with severe rigidity, dystonic posturing of both feet, and confusion of 4 days duration. His condition progressed to an akinetic-rigid state and confusion during the following week, and a routine nasopharyngeal swab tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the 9th day of onset. He developed fever and dyspnea later and was intubated on the 10th day. Conclusion To our knowledge, worsening of PD symptoms as the sole initial manifestation of SARS-CoV-2 infection, in the absence of other cardinal features of COVID-19, has not been reported in the literature. We suggest testing for COVID-19 infection in patients with PD, especially advanced cases, who present with unexplained worsening of symptoms, even in the absence of COVID-19 cardinal features.

Long term follow-up in advanced Parkinson’s disease treated with DBS of the subthalamic nucleus

2021 ◽  
Author(s):  
Maria Antonietta Volonté ◽  
Giacomo Clarizio ◽  
Sebastiano Galantucci ◽  
Pietro Giuseppe Scamarcia ◽  
Rosalinda Cardamone ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Subthalamic Nucleus ◽  
Advanced Parkinson’S Disease ◽  
Long Term Follow Up

Intracerebral Transplantation of Fetal Ventral Mesencephalon for Patients with Advanced Parkinson's Disease

1997 ◽  
Vol 69 (1-4) ◽  
pp. 99-111 ◽  
Author(s):  
Marc Levivier ◽  
Sophie Dethy ◽  
Frédéric Rodesch ◽  
Marc Peschanski ◽  
Arlette Vandesteene ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Ventral Mesencephalon ◽  
Advanced Parkinson’S Disease ◽  
Intracerebral Transplantation

scholarly journals The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson’s disease

2017 ◽  
Vol 20 (11) ◽  
pp. 1207-1215 ◽  
Author(s):  
Julia Lowin ◽  
Kavita Sail ◽  
Rakhi Baj ◽  
Yash J. Jalundhwala ◽  
Thomas S. Marshall ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Cost Effectiveness ◽  
Standard Care ◽  
Advanced Parkinson’S Disease ◽  
The Cost

scholarly journals A randomized, fixed-dose, dose–response study of ropinirole prolonged release in advanced Parkinson's disease

2017 ◽  
Vol 7 (1) ◽  
pp. 61-72 ◽  
Author(s):  
Theresa A Zesiewicz ◽  
Stephen Chriscoe ◽  
Theresa Jimenez ◽  
James Upward ◽  
Maria Davy ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Dose Response ◽  
Fixed Dose ◽  
Prolonged Release ◽  
Advanced Parkinson’S Disease ◽  
Dose Response Study

Switch from oral pramipexole or ropinirole to rotigotine transdermal system in advanced Parkinson’s disease: an open-label study

2015 ◽  
Vol 16 (7) ◽  
pp. 961-970 ◽  
Author(s):  
Sun Ju Chung ◽  
Jong-Min Kim ◽  
Jae Woo Kim ◽  
Beom Seok Jeon ◽  
Pritibha Singh ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Open Label ◽  
Advanced Parkinson’S Disease ◽  
Open Label Study ◽  
Label Study ◽  
Rotigotine Transdermal System
Sign in / Sign up

Export Citation Format

Share Document